Emerging role of long non-coding RNAs in cisplatin resistance.

Hu, Yang; Zhu, Qiong-Ni; Deng, Jun-Li; Li, Zhi-Xing; Wang, Guo; Zhu, Yuan-Shan

Hu, Yang; Zhu, Qiong-Ni; Deng, Jun-Li; Li, Zhi-Xing; Wang, Guo; Zhu, Yuan-Shan.

Afiliação

Hu Y; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Zhu QN; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China.
Deng JL; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Li ZX; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China.
Wang G; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Zhu YS; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China.

Onco Targets Ther ; 11: 3185-3194, 2018.

Article em En | MEDLINE | ID: mdl-29881292

Palavras-chave

cancer; chemoresistance; cisplatin; lncRNAs

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2018 Tipo de documento: Article País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google